307 Hospital of PLA
29
1
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
3.4%
1 terminated/withdrawn out of 29 trials
88.9%
+2.4% vs industry average
21%
6 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (29)
An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease
Role: collaborator
The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects
Role: collaborator
Ibrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged ≤65 Years
Role: collaborator
Ibrutinib Combined With Bendamustine and Rituximab in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged > 65 Years
Role: collaborator
Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy
Role: collaborator
The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma
Role: collaborator
Epidemiological Study of Neonatal Acute Respiratory Distress Syndrome (ARDS)
Role: collaborator
The Effect of RIC on TIA/Stroke in Children With Moyamoya Disease
Role: collaborator
A Phase I Study of Fluzoparib in Patient With Advanced Solid Malignancies
Role: collaborator
Application of Linked Color Imaging（LCI） in Diagnosis of Early Gastric Cancer(EGC)
Role: collaborator
Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Role: collaborator
The Natural History of Chronic Pancreatitis
Role: collaborator
A Hospital Based Survey on Lung Cancer Related-pain in Northern China
Role: collaborator
Aspergillus-specific IgG Assays for the Diagnosis of Chronic Pulmonary Aspergillosis (CPA)-Multicenter Study
Role: collaborator
Safety and Pharmacokinetics of Recombinant Anti-EGFr Antibody in Patients With Metastatic Colorectal Cancer
Role: collaborator
Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients
Role: collaborator
Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer
Role: collaborator
Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD
Role: collaborator
The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation
Role: collaborator
A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)
Role: collaborator